Olli Lohi, M.D. Ph.D., works as a chief physician in Pediatric Hematology & Oncology Division of Tampere University Hospital. Dr. Lohi received his PhD in the field of cell signaling from the University of Oulu in 1999 and did his post-doctoral training in Cambridge, UK, studying EGFR signaling. He currently leads a research group that focuses on the genomics and molecular mechanisms that lie behind the onset and evolution of childhood leukemia. Moreover, Lohi coordinates studies that aim at developing novel targeted therapies for subgroups of leukemia. Lohi serves as a co-chair of the NOPHO Leukemia & Lymphoma Biology working group and is a NOPHO representative in the ALLTogether Scientific committee.
Affiliation and contact address
Tampere Center for Child Health Research (TamCAM)
Faculty of Medicine and Health Technology
Arvo Ylpön katu 34 (P.O. Box 100)
33520 Tampere, Finland
Genomic heterogeneity of ETV6-RUNX1 leukemia